Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications

  • Emiel Ruijter
  • , Christina Van De Kaa
  • , Tilly Aalders
  • , Dirk Ruiter
  • , Gary Miller
  • , Frans Debruyne
  • , Jack Schalken
  • , F. H. Schröder
  • , C. G.M. Beeker
  • , B. G. Blijenberg
  • , A. E. Boeken Kruger
  • , I. Eman
  • , R. F. Hoedemaeker
  • , W. J. Kirkels
  • , R. Kranse
  • , Th H. Van Der Kwast
  • , M. A. Noordzij
  • , H. J.A. Van De Poel
  • , J. C. Romijn
  • , G. J. Van Steenbrugge
  • J. Trapman, N. S. Verkaik, M. J.G. Bussemakers, D. Hessels, G. O.N. Oosterhof, T. E.G. Ruijter, J. A. Schalken, C. M.G. Thomas, J. A. Witjes, A. Ylikoski, T. Lövgren, J. Lövgren, K. Pettersson, T. Piironen, S. Mansikka-Savolainen, G. Ahlgren, C. Beeker, A. Bjartell, T. Björk, H. Lilja, A. Lundwall, P. A. Abrahamsson, O. Bratt, S. Colleen, P. Elfring, H. Frederiksen, S. Mårtensson, F. C. Hamdy, H. Y. Leung, D. E. Neal, C. N. Robson

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Heterogeneous expression of E-cadherin and p53 in prostate cancer: Clinical implications'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Veterinary Science and Veterinary Medicine

Keyphrases